Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CK-101 |
Trade Name | |
Synonyms | CK101|CK 101 |
Drug Descriptions |
CK-101 is a third generation EGFR inhibitor that preferentially binds to and inhibits mutant EGFR, particularly T790M, resulting in anti-tumor activity (NCI Drug Dictionary). |
DrugClasses | EGFR Inhibitor 3rd gen 26 |
CAS Registry Number | 1660963-42-7 |
NCIT ID | C132023 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CK-101 | CK-101 | 0 | 1 |